About Equillium, Inc.
https://equilliumbio.comEquillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need.
CEO
Bruce D. Steel
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
ADAR1 CAPITAL MANAGEMENT, LLC
Shares:5.56M
Value:$6.39M
ADAGE CAPITAL PARTNERS GP, L.L.C.
Shares:5.33M
Value:$6.13M
DECHENG CAPITAL LLC
Shares:4.45M
Value:$5.11M
Summary
Showing Top 3 of 45
About Equillium, Inc.
https://equilliumbio.comEquillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $4.55M ▼ | $-4.23M ▲ | 0% | $-0.12 ▲ | $-4.2M ▲ |
| Q2-2025 | $0 | $6.2M ▼ | $-5.74M ▲ | 0% | $-0.16 ▲ | $-6.2M ▲ |
| Q1-2025 | $0 ▼ | $8.87M ▼ | $-8.65M ▼ | 0% ▲ | $-0.24 ▼ | $-8.84M ▼ |
| Q4-2024 | $4.39M ▼ | $9.09M ▼ | $-5.79M ▼ | -131.92% ▼ | $-0.16 ▼ | $-5.4M ▼ |
| Q3-2024 | $12.16M | $12.84M | $-7K | -0.06% | $-0 | $28K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $33.12M ▲ | $34.51M ▲ | $3.57M ▼ | $30.94M ▲ |
| Q2-2025 | $11.49M ▼ | $12.4M ▼ | $7.34M ▲ | $5.06M ▼ |
| Q1-2025 | $14.5M ▼ | $16.73M ▼ | $6.15M ▼ | $10.58M ▼ |
| Q4-2024 | $22.57M ▼ | $25.6M ▼ | $6.54M ▼ | $19.06M ▼ |
| Q3-2024 | $25.88M | $34.46M | $11.28M | $23.18M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-4.23M ▲ | $-8.43M ▼ | $0 | $30.07M ▲ | $21.62M ▲ | $-8.43M ▼ |
| Q2-2025 | $-5.74M ▲ | $-3.01M ▲ | $0 ▼ | $-16K ▼ | $-3.01M ▲ | $-3.01M ▲ |
| Q1-2025 | $-8.65M ▼ | $-8.17M ▼ | $4.5M ▼ | $91K ▲ | $-3.58M ▼ | $-8.17M ▼ |
| Q4-2024 | $-5.79M ▼ | $-3.3M ▲ | $6M ▼ | $73K ▲ | $2.64M ▼ | $-3.3M ▲ |
| Q3-2024 | $-7K | $-7.66M | $12M | $0 | $4.39M | $-7.66M |
CEO
Bruce D. Steel
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
ADAR1 CAPITAL MANAGEMENT, LLC
Shares:5.56M
Value:$6.39M
ADAGE CAPITAL PARTNERS GP, L.L.C.
Shares:5.33M
Value:$6.13M
DECHENG CAPITAL LLC
Shares:4.45M
Value:$5.11M
Summary
Showing Top 3 of 45